Based on the key measurements obtained from Mednax's financial statements, Mednax Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At present, Mednax's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Net Debt is expected to grow to about 433 M, whereas Other Current Liabilities is forecasted to decline to about 198.1 M. Key indicators impacting Mednax's financial strength include:
The financial analysis of Mednax is a critical element in measuring its lifeblood. Investors should not minimize Mednax's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the presentation of Mednax's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mednax's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mednax's management manipulating its earnings.
Mednax Stock Summary
Mednax competes with Acadia Healthcare, Select Medical, Universal Health, Prestige Brand, and US Physicalrapy. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Mednax's current stock value. Our valuation model uses many indicators to compare Mednax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mednax competition to find correlations between indicators driving Mednax's intrinsic value. More Info.
Mednax Inc is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . At present, Mednax's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mednax by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Mednax Inc Systematic Risk
Mednax's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mednax volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Mednax Inc correlated with the market. If Beta is less than 0 Mednax generally moves in the opposite direction as compared to the market. If Mednax Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mednax Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mednax is generally in the same direction as the market. If Beta > 1 Mednax moves generally in the same direction as, but more than the movement of the benchmark.
Mednax Thematic Clasifications
Mednax Inc is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Mednax Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mednax's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Mednax growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.14)
At present, Mednax's Price Earnings To Growth Ratio is projected to drop slightly based on the last few years of reporting.
Mednax March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mednax help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mednax Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mednax Inc based on widely used predictive technical indicators. In general, we focus on analyzing Mednax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mednax's daily price indicators and compare them against related drivers.
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.